What is Biotron Limited (BITRF) stock price today?

Biotron Limited (BITRF) is currently trading at $0.04, up 0% today.

What is BITRF P/E ratio?

Biotron Limited's P/E ratio is -6.67. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is BITRF return on equity (ROE)?

Biotron Limited's return on equity (ROE) is -119.12%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Biotron Limited's market cap?

Biotron Limited has a market capitalization of $37.63M.

OTC · Biotechnology

Biotron Limited (BITRF) Stock

$0.04 +0.00% OTC: BITRF Healthcare

Biotron Limited is an Australian biotechnology firm focused on the development and market introduction of small-molecule compounds designed to combat various viral infections. The company's primary antiviral agent, BIT225, is currently undergoing Phase II clinical trials to assess its efficacy against SARS-CoV-2, HIV-1, and hepatitis C virus infections.

Valuation

Metric	Value
Price	$0.04
Market Cap	$37.63M
P/E Ratio	-6.67
P/B Ratio	1.11
P/S Ratio	-3785.25
EPS (TTM)	$0.00
52-Week High	$0.10
52-Week Low	$0.00
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	-119.12%
ROA	-50.16%
ROCE	-71.46%
Gross Margin	190.21%
Operating Margin	—
Net Margin	—
Debt/Equity	0.00
Current Ratio	1.47

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$1.0M	$2.0M	$1.0M	$2.0M	$2.0M
Operating Profit	$-3.0M	$-3.0M	$-4.0M	$-4.0M	$0
Net Profit	$-3.0M	$-3.0M	$-3.0M	$-3.0M	$0
EPS	$0.00	$0.00	$0.00	$0.00	$0.00
Op Margin	-218.4%	-178.1%	-252.1%	-213.1%	-18.7%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$4.0M	$2.0M	$4.0M	$0	$1.0M
Total Liabilities	$0	$1.0M	$1.0M	$1.0M	$0
Cash	$4.0M	$2.0M	$4.0M	$0	$1.0M
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-3.0M	$-2.0M	$-3.0M	$-4.0M	$-1.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$1.0M
Net Cash Flow	$-3.0M	$-2.0M	$2.0M	$-4.0M	$1.0M
Free Cash Flow	$-3.0M	$-2.0M	$-3.0M	$-4.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.07
EV / EBITDA	—
FCF Yield	-2.66%
Quick Ratio	1.47
Interest Coverage	—
Return 1Y	—
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held27.10%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$336.64	-1.11%	38.93	$4.94T	0.32%
MSFTMicrosoft Corporation	$535.07	+2.38%	28.68	$3.97T	0.76%
GOOGLAlphabet Inc.	$351.66	+0.97%	16.94	$4.26T	0.26%
AMZNAmazon.com, Inc.	$262.43	+3.29%	19.82	$2.82T	0.00%
METAMeta Platforms, Inc.	$718.67	-0.31%	27.93	$1.83T	0.28%

About Biotron Limited

Biotron Limited is headquartered in AU.

Biotron Limited (BITRF) stock trades at $0.04 with a market capitalization of $37.63M. The stock is valued at a negative price-to-earnings (P/E) ratio of -6.67, reflecting a net loss over the last twelve months, price-to-book of 1.11, price-to-sales of -3785.25. Over the past 52 weeks the stock has ranged between $0.00 and $0.10, and currently trades 60.0% below its 52-week high.

On profitability, Biotron Limited generates a return on equity (ROE) of -119.12% (negative, reflecting a net loss), return on capital employed of -71.46%.

Official website: www.biotron.com.au